Neuromuscular Disease Clinical Trial
Official title:
Validation of the Measure of ETCO2, Compared to PTCO2 and PaCO2 in the Home-ventilated Neuromuscular Patient
The purpose of this study is to compare the measure of the CO2 obtained on the end-tidal expiratory gas (ETCO2) with the value of CO2 obtained by transcutaneous measure (PTCO2), in home-ventilated neuromuscular patients.
Monitoring of the effectiveness of ventilation in patients with neuromuscular require to
regularly measure blood gases and in particular carbon dioxide (CO2). The reference
technique is arterial puncture. In recent years, a non-invasive techniques measuring CO2 by
transcutaneous sensor (PTCO2) was introduced among the tools regularly used for follow-up
monitoring of home ventilated patients.
Another technique for monitoring CO2, originally developed for anesthesia, is based on the
measurement of exhaled CO2 (ETCO2). This technique requires relatively simple equipment, and
represents a potential alternative for monitoring home-ventilated patients.
Recently, sensors for ETCO2 were coupled to devices for home ventilation. To the best of our
knowledge, the role of ETCO2 in monitoring long-term ventilated patients has not been
investigated to date.
The purpose of the study is to analyze the correlation between the two non-invasive methods
for measuring CO2: PTCO2 and ETCO2, in a group of home-ventilated patients with
neuromuscular disease.
The patients will be recruited during a routine follow-up hospitalization for their
home-ventilation, and the ETCO2 will be measured during one night, in addition to the
routinely measured PTCO2.
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02847299 -
Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation
|
N/A | |
| Completed |
NCT02551406 -
Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients
|
N/A | |
| Completed |
NCT00860951 -
P300 Brain Computer Interface Keyboard to Operate Assistive Technology
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02288299 -
Long-Term Effect of LIAM on Respiratory Performance in NIV Patients Suffering From Neuromuscular Disease
|
N/A | |
| Completed |
NCT02284022 -
Clinical Validation Protocol for BCI for the Communication of Patients Suffering From Neuromuscular Disorders.
|
N/A | |
| Completed |
NCT00001201 -
Evaluation of Neuromuscular Disease
|
N/A | |
| Completed |
NCT00252252 -
AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation
|
Phase 1 | |
| Completed |
NCT02153970 -
Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy
|
||
| Terminated |
NCT02317042 -
Juno Perth Clinical Trial
|
N/A | |
| Terminated |
NCT02022072 -
Evaluation of Vital Capacity
|
Phase 2 | |
| Recruiting |
NCT04417023 -
B3 for NMD: Bench to Bedside and Back
|
||
| Recruiting |
NCT02532244 -
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
|
||
| Completed |
NCT01621984 -
Therapeutic Riding and Neuromuscular Disease
|
Phase 1 | |
| Recruiting |
NCT01900132 -
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
|
N/A | |
| Completed |
NCT00017745 -
Phenotype/Genotype Correlations in Neuromuscular Disorders
|
N/A | |
| Recruiting |
NCT01560741 -
Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive Ventilation
|
Phase 1 | |
| Completed |
NCT01644162 -
Ventilator Monitoring in Early Exacerbation Detection
|
N/A | |
| Completed |
NCT00695591 -
Home Sleep Testing in Neuromuscular Disease Patients
|
N/A | |
| Completed |
NCT01611597 -
Continuous Measurement of the Activity for Clinical Evaluation at Home, for Non-ambulant Neuromuscular Patients
|
N/A | |
| Completed |
NCT01518439 -
Instrumental and Manual Increase of Couch in Neuromuscular Patients
|
N/A |